Clonal hematopoiesis associated with epigenetic aging and clinical outcomes
Nachun, Daniel; Lu, Ake T.; Bick, Alexander G.; Natarajan, Pradeep; Weinstock, Joshua; Szeto, Mindy D.; Kathiresan, Sekar; Abecasis, Goncalo; Taylor, Kent D.; Guo, Xiuqing; Tracy, Russ; Durda, Peter; Liu, Yongmei; Johnson, Craig; Rich, Stephen S.; Van Den Berg, David; Laurie, Cecilia; Blackwell, Tom; Papanicolaou, George J.; Correa, Adolfo; Raffield, Laura M.; Johnson, Andrew D.; Murabito, Joanne; Manson, JoAnn E.; Desai, Pinkal; Kooperberg, Charles; Assimes, Themistocles L.; Levy, Daniel; Rotter, Jerome I.; Reiner, Alex P.; Whitsel, Eric A.; Wilson, James G.; Horvath, Steve; Jaiswal, Siddhartha
2021-06
View/ Open
Citation
Nachun, Daniel; Lu, Ake T.; Bick, Alexander G.; Natarajan, Pradeep; Weinstock, Joshua; Szeto, Mindy D.; Kathiresan, Sekar; Abecasis, Goncalo; Taylor, Kent D.; Guo, Xiuqing; Tracy, Russ; Durda, Peter; Liu, Yongmei; Johnson, Craig; Rich, Stephen S.; Van Den Berg, David; Laurie, Cecilia; Blackwell, Tom; Papanicolaou, George J.; Correa, Adolfo; Raffield, Laura M.; Johnson, Andrew D.; Murabito, Joanne; Manson, JoAnn E.; Desai, Pinkal; Kooperberg, Charles; Assimes, Themistocles L.; Levy, Daniel; Rotter, Jerome I.; Reiner, Alex P.; Whitsel, Eric A.; Wilson, James G.; Horvath, Steve; Jaiswal, Siddhartha (2021). "Clonal hematopoiesis associated with epigenetic aging and clinical outcomes." Aging Cell (6): n/a-n/a.
Abstract
Clonal hematopoiesis of indeterminate potential (CHIP) is a common precursor state for blood cancers that most frequently occurs due to mutations in the DNA‐methylation modifying enzymes DNMT3A or TET2. We used DNA‐methylation array and whole‐genome sequencing data from four cohorts together comprising 5522 persons to study the association between CHIP, epigenetic clocks, and health outcomes. CHIP was strongly associated with epigenetic age acceleration, defined as the residual after regressing epigenetic clock age on chronological age, in several clocks, ranging from 1.31 years (GrimAge, p < 8.6 × 10−7) to 3.08 years (EEAA, p < 3.7 × 10−18). Mutations in most CHIP genes except DNA‐damage response genes were associated with increases in several measures of age acceleration. CHIP carriers with mutations in multiple genes had the largest increases in age acceleration and decrease in estimated telomere length. Finally, we found that ~40% of CHIP carriers had acceleration >0 in both Hannum and GrimAge (referred to as AgeAccelHG+). This group was at high risk of all‐cause mortality (hazard ratio 2.90, p < 4.1 × 10−8) and coronary heart disease (CHD) (hazard ratio 3.24, p < 9.3 × 10−6) compared to those who were CHIP−/AgeAccelHG−. In contrast, the other ~60% of CHIP carriers who were AgeAccelHG− were not at increased risk of these outcomes. In summary, CHIP is strongly linked to age acceleration in multiple clocks, and the combination of CHIP and epigenetic aging may be used to identify a population at high risk for adverse outcomes and who may be a target for clinical interventions.Clonal hematopoiesis of indeterminate potential (CHIP) and epigenetic age acceleration are the two important aging phenomenon associated with adverse clinical outcomes. We found that mutations in most CHIP genes were associated with increased age acceleration in multiple epigenetic clocks. Individuals with CHIP and age acceleration had a greatly increased risk of mortality and coronary heart disease compared to individuals with only CHIP or age acceleration.Publisher
Springer, New York Wiley Periodicals, Inc.
ISSN
1474-9718 1474-9726
Other DOIs
Types
Article
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.